RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Stockholders' equity

CATALYST PHARMACEUTICALS, INC.CPRX

Market cap
$2.8B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2024728+87.59%
Dec 31, 2023388+29.11%
Dec 31, 2022300+45.25%
Dec 31, 2021207+21.95%
Dec 31, 2020170+93.54%
Dec 31, 201988+72.55%
Dec 31, 201851-37.28%
Dec 31, 201781+105.97%
Dec 31, 201639-29.14%
Dec 31, 201555+57.41%
Dec 31, 201435+64.75%
Dec 31, 201321+46.29%
Dec 31, 201215+288.81%
Dec 31, 20114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)